Novartis AG (NVS)
97.44
-1.62
(-1.64%)
USD |
NYSE |
Apr 26, 16:00
97.46
+0.02
(+0.02%)
After-Hours: 20:00
Novartis Total Return Level: 203.80 for April 26, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
April 26, 2024 | 203.80 |
April 25, 2024 | 207.19 |
April 24, 2024 | 205.71 |
April 23, 2024 | 203.47 |
April 22, 2024 | 198.95 |
April 19, 2024 | 197.36 |
April 18, 2024 | 193.62 |
April 17, 2024 | 194.69 |
April 16, 2024 | 194.94 |
April 15, 2024 | 197.47 |
April 12, 2024 | 195.61 |
April 11, 2024 | 197.32 |
April 10, 2024 | 197.40 |
April 09, 2024 | 200.40 |
April 08, 2024 | 199.70 |
April 05, 2024 | 200.35 |
April 04, 2024 | 202.65 |
April 03, 2024 | 197.38 |
April 02, 2024 | 197.47 |
April 01, 2024 | 200.52 |
March 28, 2024 | 202.32 |
March 27, 2024 | 200.54 |
March 26, 2024 | 199.27 |
March 25, 2024 | 200.23 |
March 22, 2024 | 201.27 |
Date | Value |
---|---|
March 21, 2024 | 200.96 |
March 20, 2024 | 200.90 |
March 19, 2024 | 201.46 |
March 18, 2024 | 200.63 |
March 15, 2024 | 203.45 |
March 14, 2024 | 205.25 |
March 13, 2024 | 207.07 |
March 12, 2024 | 208.68 |
March 11, 2024 | 212.02 |
March 08, 2024 | 210.64 |
March 07, 2024 | 209.01 |
March 06, 2024 | 206.86 |
March 05, 2024 | 205.77 |
March 04, 2024 | 205.51 |
March 01, 2024 | 205.69 |
February 29, 2024 | 203.50 |
February 28, 2024 | 206.02 |
February 27, 2024 | 207.89 |
February 26, 2024 | 208.09 |
February 23, 2024 | 209.40 |
February 22, 2024 | 207.18 |
February 21, 2024 | 206.70 |
February 20, 2024 | 207.02 |
February 16, 2024 | 201.92 |
February 15, 2024 | 200.80 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
126.19
Minimum
Mar 23 2020
218.61
Maximum
Jan 22 2024
168.67
Average
162.53
Median
Jan 14 2020
Total Return Level Benchmarks
Sandoz Group AG | 32.80 |
Amgen Inc | 375.33 |
AstraZeneca PLC | 215.24 |
Incyte Corp | 51.68 |
MorphoSys AG | 18.04 |